Price Alert

Prestige Consumer Healthc... (PBH)

NYSE: PBH · Real-Time Price · USD

64.58

-1.85 (-2.78%)

At close: Aug 14, 2025, 3:59 PM

64.60

0.03%

After-hours: Aug 14, 2025, 05:54 PM EDT

-2.78% (1D)

Bid	62
Market Cap	3.18B
Revenue (ttm)	1.12B
Net Income (ttm)	213M
EPS (ttm)	4.26
PE Ratio (ttm)	15.16
Forward PE	13.76
Analyst	Buy

Ask	74.2
Volume	535,200
Avg. Volume (20D)	418,159
Open	66.00
Previous Close	66.43
Day's Range	64.01 - 66.00
52-Week Range	62.95 - 90.04
Beta	0.44

About PBH

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PBH

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PBH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Prestige Consumer Healthcare has released their quartely earnings on Aug 7, 2025:

Revenue of $249.53M misses estimates by $11.45M, with -6.59% YoY decline.

EPS of 0.95 misses estimates by -0.05, with 5.56% YoY growth.

Next Earnings Release

Prestige Consumer Healthcare Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-10.05%

Prestige Consumer Healthcare shares are trading lo... Unlock content with Pro Subscription

3 months ago

+6.92%

Prestige Consumer Healthcare shares are trading higher after the company reported a Q4 adjusted EPS beat.

News

1 week ago · seekingalpha.com

Prestige Consumer Healthcare Inc. (PBH) Q1 2026 Earnings Call Transcript

Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q1 2026 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Christine Sacco - CFO & COO Philip David Terpolilli - Director of Investor...

1 week ago · zacks.com

Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $0.95 per share, missing the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $0.9 per share a year ago.

1 week ago · zacks.com

Stay Ahead of the Game With Prestige Consumer Healthcare (PBH) Q1 Earnings: Wall Street's Insights on Key Metrics

Beyond analysts' top-and-bottom-line estimates for Prestige Consumer Healthcare (PBH), evaluate projections for some of its key metrics to gain a better insight into how the business might have perfor...

1 month ago · zacks.com

Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 months ago · zacks.com

Should You Continue to Hold Prestige Consumer Stock in Your Portfolio?

PBH rides strong on e-commerce gains and brand innovations, but debt load and forex risks cast a shadow on future growth.

2 months ago · zacks.com

PBH vs. SYK: Which Stock Is the Better Value Option?

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?

2 months ago · zacks.com

Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock?

PBH stock jumps on the back of brand strength, e-commerce gains and smart acquisitions despite tariff and foreign exchange headwinds.